(Q44227814)

English

The impact of dose escalation and resistance modulation in older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome: the results of the LRF AML14 trial

scientific article

Statements

The impact of dose escalation and resistance modulation in older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome: the results of the LRF AML14 trial (English)
Archibald Prentice
Mary-Frances McMullin
Elizabeth Sellwood
United Kingdom National Cancer Research Institute Haematological Oncology Study Group

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit